These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 24751900)

  • 21. Identification of a coordinated CD8 and CD4 T cell response directed against mismatched HLA Class I causing severe acute graft-versus-host disease.
    Amir AL; Hagedoorn RS; van Luxemburg-Heijs SA; Marijt EW; Kruisselbrink AB; Frederik Falkenburg JH; Heemskerk MH
    Biol Blood Marrow Transplant; 2012 Feb; 18(2):210-9. PubMed ID: 22015995
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human leukocyte antigen class I-restricted activation of CD8+ T cells provides the immunogenetic basis of a systemic drug hypersensitivity.
    Chessman D; Kostenko L; Lethborg T; Purcell AW; Williamson NA; Chen Z; Kjer-Nielsen L; Mifsud NA; Tait BD; Holdsworth R; Almeida CA; Nolan D; Macdonald WA; Archbold JK; Kellerher AD; Marriott D; Mallal S; Bharadwaj M; Rossjohn J; McCluskey J
    Immunity; 2008 Jun; 28(6):822-32. PubMed ID: 18549801
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dendritic cells engineered to express defined allo-HLA peptide complexes induce antigen-specific cytotoxic T cells efficiently killing tumour cells.
    Stronen E; Abrahamsen IW; Gaudernack G; Wälchli S; Munthe E; Buus S; Johansen FE; Lund-Johansen F; Olweus J
    Scand J Immunol; 2009 Apr; 69(4):319-28. PubMed ID: 19284496
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Abacavir adverse reactions related with HLA-B*57: 01 haplotype in a large cohort of patients infected with HIV.
    Quiros-Roldan E; Gardini G; Properzi M; Ferraresi A; Carella G; Marchi A; Malagoli A; Focà E; Castelli F
    Pharmacogenet Genomics; 2020 Oct; 30(8):167-174. PubMed ID: 32453265
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Priming of Allo-HLA-DP-Specific Reactivity from the Naïve T Cell Compartment Is Not Exclusively Mediated by Professional Antigen-Presenting Cells.
    Laghmouchi A; Hoogstraten C; Falkenburg JHF; Jedema I
    Biol Blood Marrow Transplant; 2020 Jul; 26(7):1257-1265. PubMed ID: 32165326
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of Abacavir-Induced Structural Alterations in Human Leukocyte Antigen-B*57 : 01 Using Phage Display.
    Shirayanagi T; Aoki S; Fujimori S; Watanabe K; Aida T; Hirasawa M; Kumagai K; Hoshino T; Ito K
    Biol Pharm Bull; 2020; 43(6):1007-1015. PubMed ID: 32475910
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A similarity in peptide cross-reactivity between alloantigen- and nominal antigen-induced CD8+ T cell responses in vitro.
    Yu Q; Zhang L; Ouyang L; Gong Y; Liang Z; Shen G; Weng X; Wu X
    Immunogenetics; 2013 Mar; 65(3):173-84. PubMed ID: 23233149
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dapsone- and nitroso dapsone-specific activation of T cells from hypersensitive patients expressing the risk allele HLA-B*13:01.
    Zhao Q; Alhilali K; Alzahrani A; Almutairi M; Amjad J; Liu H; Sun Y; Sun L; Zhang H; Meng X; Gibson A; Ogese MO; Kevin Park B; Liu J; Ostrov DA; Zhang F; Naisbitt DJ
    Allergy; 2019 Aug; 74(8):1533-1548. PubMed ID: 30844087
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [HLA-B*5701 and abacavir hypersensitivity reaction].
    Servonnet A; Leclercq E; Delacour H; Ceppa F
    Pathol Biol (Paris); 2010 Dec; 58(6):e95-100. PubMed ID: 19243901
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Abacavir inhibits but does not cause self-reactivity to HLA-B*57:01-restricted EBV specific T cell receptors.
    Sooda A; Rwandamuriye F; Wanjalla CN; Jing L; Koelle DM; Peters B; Leary S; Chopra A; Calderwood MA; Mallal SA; Pavlos R; Watson M; Phillips EJ; Redwood AJ
    Commun Biol; 2022 Feb; 5(1):133. PubMed ID: 35173258
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stimulation of HIV-specific T cell clonotypes using allogeneic HLA.
    Almeida CA; van Miert P; O'Driscoll K; Zoet YM; Chopra A; Watson M; de Santis D; Witt C; John M; Claas FHJ; D'Orsogna LJ
    Cell Immunol; 2017 Jun; 316():32-40. PubMed ID: 28372798
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Direct visualization of cross-reactive effector and memory allo-specific CD8 T cells generated in response to viral infections.
    Brehm MA; Markees TG; Daniels KA; Greiner DL; Rossini AA; Welsh RM
    J Immunol; 2003 Apr; 170(8):4077-86. PubMed ID: 12682237
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Active suppression rather than ignorance: tolerance to abacavir-induced HLA-B*57:01 peptide repertoire alteration.
    Phillips EJ; Mallal SA
    J Clin Invest; 2018 Jul; 128(7):2746-2749. PubMed ID: 29781810
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intracellular cytokines may model immunoregulation of abacavir hypersensitivity in HIV-infected subjects.
    King D; Tomkins S; Waters A; Easterbrook PJ; Thurmond LM; Thorborn DE; Raffi F; Kemeny DM; Vyakarnam A
    J Allergy Clin Immunol; 2005 May; 115(5):1081-7. PubMed ID: 15867870
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A simple screening approach to reduce B*5701-associated abacavir hypersensitivity on the basis of sequence variation in HIV reverse transcriptase.
    Chui CK; Brumme ZL; Brumme CJ; Yip B; Phillips EJ; Montaner JS; Harrigan PR
    Clin Infect Dis; 2007 Jun; 44(11):1503-8. PubMed ID: 17479950
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alloreactive and leukemia-reactive T cells are preferentially derived from naive precursors in healthy donors: implications for immunotherapy with memory T cells.
    Distler E; Bloetz A; Albrecht J; Asdufan S; Hohberger A; Frey M; Schnürer E; Thomas S; Theobald M; Hartwig UF; Herr W
    Haematologica; 2011 Jul; 96(7):1024-32. PubMed ID: 21486863
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of a naturally processed NY-ESO-1 peptide recognized by CD8+ T cells in the context of HLA-B51.
    Jäger E; Karbach J; Gnjatic S; Jäger D; Maeurer M; Atmaca A; Arand M; Skipper J; Stockert E; Chen YT; Old LJ; Knuth A
    Cancer Immun; 2002 Sep; 2():12. PubMed ID: 12747757
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predisposition to abacavir hypersensitivity conferred by HLA-B*5701 and a haplotypic Hsp70-Hom variant.
    Martin AM; Nolan D; Gaudieri S; Almeida CA; Nolan R; James I; Carvalho F; Phillips E; Christiansen FT; Purcell AW; McCluskey J; Mallal S
    Proc Natl Acad Sci U S A; 2004 Mar; 101(12):4180-5. PubMed ID: 15024131
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytokine profiling in abacavir hypersensitivity patients.
    Almeida CA; Martin AM; Nolan D; Lucas A; Cameron PU; James I; Phillips E; Mallal S
    Antivir Ther; 2008; 13(2):281-8. PubMed ID: 18505179
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Carbamazepine Induces Focused T Cell Responses in Resolved Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Cases But Does Not Perturb the Immunopeptidome for T Cell Recognition.
    Mifsud NA; Illing PT; Lai JW; Fettke H; Hensen L; Huang Z; Rossjohn J; Vivian JP; Kwan P; Purcell AW
    Front Immunol; 2021; 12():653710. PubMed ID: 33912179
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.